Page results
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Information about our UCLH Charity, charity funds and associated charities.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
UCLH is the first NHS trust to pilot a personalised educational package for patients living with stroke.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
Our staff have rated UCLH as the top trust in England, improving on our ranking from last year when we were third best in England and top in London.
-
UCLH will play a vital role in a new respiratory virus study.
-
This page explains what patient-initiated follow-up (PIFU) involves after your treatment for endometrial (uterine or womb) cancer.
-
RESPOND – Information for healthcare professionals and services working with asylum seekers
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
File results
-
FOI/2022/0541 - Serious Incidents Level 2 deaths/ serious harm
-
FOI/2022/0576 - Medications within dermatology
-
FOI/2022/0577 - Injuries relating to e-scooters, cycling and moterbikes
-
FOI/2022/0580 - Number of occasions when there were no out-of-hours GPs on shift
-
FOI/2022/0584 - Clinical negligence claims in the maternity department and damages paid
-
FOI/2022/0585 - Racial abuse by patients towards staff
-
FOI/2022/0586 - Individuals who have sought help from GPs or addiction services in relation to addiction to pornography
-
FOI/2022/0589 - Multiple sclerosis treatment
-
FOI/2022/0590 - Private patient unit revenue
-
FOI/2022/0591 - Maternity guidelines relating to obesity